Geneos Wealth Management’s Unitil UTL Stock Holding History

Geneos Wealth Management’s Portfolio UTL Stock Details UTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19	Closed	-$991	–	3165
2025 Q2	$991	Buy	+19	New	+$1.05K	﹤0.01%	2986

Other funds holding UTL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geneos Wealth Management's UTL Position: Q3 2025 in Review

Geneos Wealth Management sold out of Unitil (UTL) in Q3 2025, closing a stake of 19 shares — an estimated $991 sold.

Geneos Wealth Management first reported a position in UTL in Q2 2025 and held it in 1 quarter. The position peaked at $991 in Q2 2025. 217 funds tracked by Wall St. Rank hold UTL as of Q3 2025.

Geneos Wealth Management reported no remaining Unitil position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 19 Unitil shares in Q3 2025, an estimated $991.
Geneos Wealth Management first reported a position in Unitil in Q2 2025 and held it in 1 quarter.
Geneos Wealth Management's Unitil position peaked at $991 in Q2 2025.
217 funds tracked by Wall St. Rank held Unitil as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.